These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
362 related items for PubMed ID: 9629991
1. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers. Bawazir SA, Gouda MW, El-Sayed YM, Al-Khamis KI, Al-Yamani MJ, Niazy EM, Al-Rashood KA. Int J Clin Pharmacol Ther; 1998 May; 36(5):270-4. PubMed ID: 9629991 [Abstract] [Full Text] [Related]
2. Comparative bioavailability of two tablet formulations of acyclovir in healthy volunteers. Al-Yamani MJ, Al-Khamis KI, El-Sayed YM, Bawazir SA, Al-Rashood KA, Gouda MW. Int J Clin Pharmacol Ther; 1998 Apr; 36(4):222-6. PubMed ID: 9587049 [Abstract] [Full Text] [Related]
3. Comparative bioavailability of two tablet formulations of ibuprofen. el-Sayed YM, Gouda MW, al-Khamis KI, al-Meshal MA, al-Dhawailie AA, al-Rayes S, Bin-Salih SA, al-Rashood KA. Int J Clin Pharmacol Ther; 1995 May; 33(5):294-8. PubMed ID: 7655769 [Abstract] [Full Text] [Related]
4. Comparative bioavailability of two tablet formulations of metoclopramide hydrochloride. el-Sayed YM, Niazy EM, al-Rayes S, Ismail AO, Gouda MW. Int J Clin Pharmacol Ther; 1995 Mar; 33(3):136-9. PubMed ID: 7599911 [Abstract] [Full Text] [Related]
5. Effect of gastric emptying and entero-hepatic circulation on bioequivalence assessment of ranitidine. Chrenova J, Durisova M, Mircioiu C, Dedik L. Methods Find Exp Clin Pharmacol; 2010 Mar; 32(6):413-9. PubMed ID: 20852750 [Abstract] [Full Text] [Related]
6. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S. Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [Abstract] [Full Text] [Related]
7. Bioequivalence and pharmacokinetics of chlorpheneramine in healthy human volunteers. Najjar TA, Al-Alsheikh OA, Al-Dhawailie AA, Shereif A. Int J Clin Pharmacol Ther; 1995 Nov; 33(11):619-22. PubMed ID: 8688987 [Abstract] [Full Text] [Related]
8. Pharmacokinetics and bioequivalence study of ranitidine film tablets in healthy male subjects. Gschwend MH, Guserle R, Erenmemişoglu A, Martin W, Tamur U, Kanzik I, Hincal AA. Arzneimittelforschung; 2007 Nov; 57(6):315-9. PubMed ID: 17688076 [Abstract] [Full Text] [Related]
9. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers. Bittner B, Riek M, Holmes B, Grange S. Antivir Ther; 2005 Nov; 10(7):803-10. PubMed ID: 16312177 [Abstract] [Full Text] [Related]
10. Evaluation of the bioequivalence of zidovudine 100 mg capsules in healthy Thai male volunteers. Chompootaweep S, Poonsrisawat J, Xumseang P. J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S79-85. PubMed ID: 17722305 [Abstract] [Full Text] [Related]
11. Bioequivalence of two oral formulations of triflusal capsules in healthy volunteers. Quetglas EG, Campanero MA, Sádaba B, Escolar M, Azanza JR. Arzneimittelforschung; 2008 Sep; 58(6):283-7. PubMed ID: 18677970 [Abstract] [Full Text] [Related]
12. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA. Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [Abstract] [Full Text] [Related]
13. Bioequivalence of two lamivudine tablet formulations. Santos-Magalhães NS, Pontes A, Cavalcante RM, Costa RM, Rangel FA, Guimarães MI, de Carvalho JN, de Souza SD, de Oliveira HM, Esteves IL, Ramalho MS, Vieira SL, Alves AJ. Arzneimittelforschung; 2001 Oct; 51(4):310-4. PubMed ID: 11367872 [Abstract] [Full Text] [Related]
14. [Bioequivalence and bioavailability after single administration of effervescent ranitidine tablets]. Hartmann B, Schmieder G, Tetzloff W, Töberich H. Arzneimittelforschung; 1992 Aug; 42(8):1020-2. PubMed ID: 1418073 [Abstract] [Full Text] [Related]
15. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers. Rhim SY, Park JH, Park YS, Lee MH, Kim DS, Shaw LM, Yang SC, Kang JS. Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104 [Abstract] [Full Text] [Related]
16. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M. Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [Abstract] [Full Text] [Related]
17. A randomized, open-label pharmacokinetic comparison of two oral formulations of fluconazole 150 mg in healthy adult volunteers. Jovanović D, Kilibarda V, Cirić B, Vucinić S, Srnić D, Vehabović M, Potogija N. Clin Ther; 2005 Oct; 27(10):1588-95. PubMed ID: 16330294 [Abstract] [Full Text] [Related]
18. Relative bioavailability of different butamirate citrate preparations after single dose oral administration to 18 healthy volunteers. Bohner H, Janiak PS, Nitsche V, Eichinger A, Schütz H. Int J Clin Pharmacol Ther; 1997 Mar; 35(3):117-22. PubMed ID: 9089001 [Abstract] [Full Text] [Related]
19. Comparative bioavailability of two dexamethasone tablet formulations in Indonesian healthy volunteers. Harahap Y, Sasongko L, Prasaja B, Indriati E, Lusthom W, Lipin. Arzneimittelforschung; 2009 Mar; 59(4):191-4. PubMed ID: 19517895 [Abstract] [Full Text] [Related]
20. Bioequivalence study of two losartan formulations administered orally in healthy male volunteers. Bienert A, Brzezińiski R, Szałek E, Dubai V, Grześkowiak E, Dyderski S, Drobnik L, Wolc A, Olejniczak-Rabinek M. Arzneimittelforschung; 2006 Mar; 56(11):723-8. PubMed ID: 17220048 [Abstract] [Full Text] [Related] Page: [Next] [New Search]